News from DS Biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

06 Jan, 2017, 07:00 ET DS Biopharma (DS) Announces that Recruitment has Begun in Two Separate Phase 2b Atopic Dermatitis Studies with Lead Compound DS107 as well as the Successful Completion of a Phase 1 Trial for Follow on Compound DS109

DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has...


29 Sep, 2016, 02:00 ET DS Biopharma Will Today Present Data on a Phase IIa Study at the European Academy of Dermatology and Venereology (EADV) Congress

DS Biopharma (DS) will today present data on their Phase IIa study with DS107 for the treatment of atopic dermatitis at the 25th European Academy...


14 Sep, 2016, 02:00 ET DS Biopharma Announces the Appointment of Dr. Markus Weissbach as Chief Operating Officer

DS Biopharma (DS) today announced the appointment of Dr. Markus Weissbach (MD, PhD) to the position of Chief Operating Officer. Markus is...


22 Aug, 2016, 02:00 ET DS Biopharma (DS) Announces Spin-out Company Focused on Fibrotic Conditions and Pulmonary Disorders

Afimmune will continue development of DS102  DS Biopharma will focus on dermatological conditions  DS Biopharma (DS), a privately held...


23 May, 2016, 02:00 ET DS Biopharma Announces DS102 will be Developed for Pulmonary Disorders in Addition to NASH

DS Biopharma (DS) today announced plans to develop its anti-fibrotic and anti-inflammatory compound DS102 in chronic obstructive pulmonary disease...


07 Jan, 2016, 02:00 ET DS Biopharma Announces Positive Top-line Phase IIa Trial Results for DS107 as an Oral Treatment for Moderate to Severe Atopic Dermatitis

DS Biopharma (DS), a privately held biopharmaceutical company, today announced positive top-line results from a Phase IIa clinical trial of oral...


18 Dec, 2015, 02:00 ET DS Biopharma Announces Successful Completion of a Phase I Safety Study With Bioactive Lipid DS102 Which is Targeting NASH and IPF

DS Biopharma, a privately held biopharmaceutical company, today announced the successful completion of a Phase I trial with an oral formulation of...


09 Nov, 2015, 02:18 ET DS Biopharma Obtains a Granted Patent Covering the Use of DS102 to Treat Fatty Liver Disorders

DS Biopharma, a biopharmaceutical company, announced today that its patent covering the use of bioactive active pharmaceutical ingredient (API)...


25 Sep, 2015, 02:00 ET DS Biopharma Appoints Leopoldo Zambeletti as Non-Executive Director

DS Biopharma, a privately held biopharmaceutical company, today announced the appointment of Leopoldo Zambeletti as a Non-Executive Director to...